• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018
  • New Vizit Bibliography pane January 8, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

REMICADE

TNF inhibitors and the microbiome

August 24, 2018Autoimmune Diseases, Microbiome, Vizit Graphs
TNF inhibitors and the microbiome

Study microbiota of patients treated with TNF inhibitors with Biovista Vizit. Explore the live graph.

Hepatitis and Autoimmune Diseases Drugs

August 24, 2018Autoimmune Diseases, Hepatitis, Vizit Graphs
Hepatitis and Autoimmune Diseases Drugs

Managing infections and autoimmunity with Remicade and Ribavirin. Explore the live graph.

Vizit Graphs Tag Cloud

CLOSTRIDIUM DIFFICILE ERBB-2 STREPTOCOCCUS PNEUMONIAE ALZHEIMER'S DISEASE IL17A CELL DIFFERENTIATION IL23A TNF IFNG SOD1 CELL DEATH PARKINSON DISEASE METFORMIN RECEPTOR TH17 CELLS AGING AUTOPHAGY RHEUMATOID ARTHRITIS CANDIDA ALBICANS IMMUNE RESPONSE BREAST CANCER INSULIN CTLA4 APOPTOTIC PROCESS LISTERIA MONOCYTOGENES TP53 PORPHYROMONAS GINGIVALIS CASP3 CANCER 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE INFLAMMATION CELL PROLIFERATION DOXORUBICIN PSEUDOMONAS AERUGINOSA HELICOBACTER PYLORI NEURODEGENERATIVE DISORDERS CD4 STAPHYLOCOCCUS AUREUS ANGIOGENESIS FOXP3 IL6 REMICADE ESCHERICHIA COLI CELL DIVISION DIABETES MELLITUS

© 2019 Biovista Vizit All Rights Reserved.